PMID- 20217131 OWN - NLM STAT- MEDLINE DCOM- 20101027 LR - 20220310 IS - 1432-1335 (Electronic) IS - 0171-5216 (Print) IS - 0171-5216 (Linking) VI - 136 IP - 11 DP - 2010 Nov TI - Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells. PG - 1697-707 LID - 10.1007/s00432-010-0828-5 [doi] AB - PURPOSE: Hypoxia in tumors is generally associated with chemoresistance and radioresistance. However, the correlation between the heterodimeric hypoxia-inducible factor-1 (HIF-1) and the multidrug resistance (MDR1) gene/transporter P-glycoprotein (P-gp) has not been clearly investigated. This study aims at examining the expression levels of HIF-1alpha and MDR1/P-gp in human colon carcinoma tissues and cell lines (HCT-116, HT-29, LoVo, and SW480) and ascertaining whether HIF-1alpha plays an important role in tumor multidrug resistance with MDR1/P-gp. METHODS: The expression and distribution of HIF-1alpha and P-gp proteins were detected in human colon carcinoma tissues and cell lines by immunohistochemistry and immunocytochemistry using streptavidin/peroxidase (SP) and double-label immunofluorescence methods. HIF-1alpha and MDR1 mRNA expression levels in cell lines were analyzed using RT-PCR under normoxic and hypoxic conditions, respectively. RESULTS: The immunohistochemical method shows that HIF-1alpha and P-gp expression were not correlated with gender, age, location, and differentiation degree (P > 0.05). However, the expression of HIF-1alpha and P-gp at different Dukes' stages and whether involved in lymphatic invasion shows a significant difference (P < 0.05). Correlation analysis displays that HIF-1alpha protein expression was correlated significantly with P-gp expression (P < 0.01). Double-label immunofluorescence demonstrates that coexpression of HIF-1alpha and P-gp does exist in human colon carcinoma tissues. The mRNA expression of HIF-1alpha and MDR1 was detected in the four human colon carcinoma cell lines under both normoxia and hypoxia. Optical density values representing mRNA expression levels of HIF-1alpha and MDR1 were found to be significantly higher in the same type cells under hypoxic conditions than that under normoxic conditions, respectively (P < 0.01). However, no significant differences of HIF-1alpha or MDR1 mRNA expression were found among these cell lines, which exposed under the same PaO(2) cultural conditions (P > 0.05). And the immunocytochemistry results were corresponding with the analysis of mRNA expression. CONCLUSIONS: These results suggest that hypoxia induce the expression of HIF-1alpha and MDR1/P-gp in colon carcinoma and HIF-1alpha expression may be associated with the gene MDR1 (P-gp) and interactively involved in the occurrence of tumor multidrug resistance. FAU - Ding, Zhenyu AU - Ding Z AD - Department of Oncology, Southwest Hospital, Third Military Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China. FAU - Yang, Li AU - Yang L FAU - Xie, Xiaodong AU - Xie X FAU - Xie, Fangwei AU - Xie F FAU - Pan, Feng AU - Pan F FAU - Li, Jianjun AU - Li J FAU - He, Jianming AU - He J FAU - Liang, Houjie AU - Liang H LA - eng PT - Journal Article DEP - 20100309 PL - Germany TA - J Cancer Res Clin Oncol JT - Journal of cancer research and clinical oncology JID - 7902060 RN - 0 (ABCB1 protein, human) RN - 0 (ATP Binding Cassette Transporter, Subfamily B) RN - 0 (ATP Binding Cassette Transporter, Subfamily B, Member 1) RN - 0 (DNA Primers) RN - 0 (HIF1A protein, human) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) SB - IM MH - ATP Binding Cassette Transporter, Subfamily B MH - ATP Binding Cassette Transporter, Subfamily B, Member 1/*genetics MH - Aged MH - Cell Differentiation MH - Cell Line, Tumor MH - Colonic Neoplasms/*genetics/pathology MH - DNA Primers MH - Female MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Hypoxia-Inducible Factor 1, alpha Subunit/*genetics MH - Immunohistochemistry MH - Male MH - Middle Aged MH - Neoplasm Invasiveness MH - Reverse Transcriptase Polymerase Chain Reaction PMC - PMC2944968 EDAT- 2010/03/11 06:00 MHDA- 2010/10/28 06:00 PMCR- 2010/03/09 CRDT- 2010/03/11 06:00 PHST- 2009/01/31 00:00 [received] PHST- 2010/02/08 00:00 [accepted] PHST- 2010/03/11 06:00 [entrez] PHST- 2010/03/11 06:00 [pubmed] PHST- 2010/10/28 06:00 [medline] PHST- 2010/03/09 00:00 [pmc-release] AID - 828 [pii] AID - 10.1007/s00432-010-0828-5 [doi] PST - ppublish SO - J Cancer Res Clin Oncol. 2010 Nov;136(11):1697-707. doi: 10.1007/s00432-010-0828-5. Epub 2010 Mar 9.